United States Cholera Vaccine Market Report 2017

December 2017 | 101 pages | ID: U64C99F4280EN
QYResearch

Abstracts

In this report, the United States Cholera Vaccine market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

• The West
• Southwest
• The Middle Atlantic
• New England
• The South
• The Midwest
• with sales (volume), revenue (value), market share and growth rate of Cholera Vaccine in these regions, from 2012 to 2022 (forecast).

United States Cholera Vaccine market competition by top manufacturers/players, with Cholera Vaccine sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

• Valneva
• PaxVax
• Shantha Biotechnics Limited
• Celldex Therapeutics
• Merck
• Ceva Asia

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

• Dukoral
• Shanchol
• Vaxchora
• Others

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate for each application, including

• Hospital
• Scientific Research
• Others

If you have any special requirements, please let us know and we will offer you the report as you want.

Contents

United States Cholera Vaccine Market Report 2017

1 CHOLERA VACCINE OVERVIEW

1.1 Product Overview and Scope of Cholera Vaccine
1.2 Classification of Cholera Vaccine by Product Category
  1.2.1 United States Cholera Vaccine Market Size (Sales Volume) Comparison by Type (2012-2022)
  1.2.2 United States Cholera Vaccine Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
  1.2.3 Dukoral
  1.2.4 Shanchol
  1.2.5 Vaxchora
  1.2.6 Others
1.3 United States Cholera Vaccine Market by Application/End Users
  1.3.1 United States Cholera Vaccine Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
  1.3.2 Hospital
  1.3.3 Scientific Research
  1.3.4 Others
1.4 United States Cholera Vaccine Market by Region
  1.4.1 United States Cholera Vaccine Market Size (Value) Comparison by Region (2012-2022)
  1.4.2 The West Cholera Vaccine Status and Prospect (2012-2022)
  1.4.3 Southwest Cholera Vaccine Status and Prospect (2012-2022)
  1.4.4 The Middle Atlantic Cholera Vaccine Status and Prospect (2012-2022)
  1.4.5 New England Cholera Vaccine Status and Prospect (2012-2022)
  1.4.6 The South Cholera Vaccine Status and Prospect (2012-2022)
  1.4.7 The Midwest Cholera Vaccine Status and Prospect (2012-2022)
1.5 United States Market Size (Value and Volume) of Cholera Vaccine (2012-2022)
  1.5.1 United States Cholera Vaccine Sales and Growth Rate (2012-2022)
  1.5.2 United States Cholera Vaccine Revenue and Growth Rate (2012-2022)

2 UNITED STATES CHOLERA VACCINE MARKET COMPETITION BY PLAYERS/SUPPLIERS

2.1 United States Cholera Vaccine Sales and Market Share of Key Players/Suppliers (2012-2017)
2.2 United States Cholera Vaccine Revenue and Share by Players/Suppliers (2012-2017)
2.3 United States Cholera Vaccine Average Price by Players/Suppliers (2012-2017)
2.4 United States Cholera Vaccine Market Competitive Situation and Trends
  2.4.1 United States Cholera Vaccine Market Concentration Rate
  2.4.2 United States Cholera Vaccine Market Share of Top 3 and Top 5 Players/Suppliers
  2.4.3 Mergers & Acquisitions, Expansion in United States Market
2.5 United States Players/Suppliers Cholera Vaccine Manufacturing Base Distribution, Sales Area, Product Type

3 UNITED STATES CHOLERA VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY REGION (2012-2017)

3.1 United States Cholera Vaccine Sales and Market Share by Region (2012-2017)
3.2 United States Cholera Vaccine Revenue and Market Share by Region (2012-2017)
3.3 United States Cholera Vaccine Price by Region (2012-2017)

4 UNITED STATES CHOLERA VACCINE SALES (VOLUME) AND REVENUE (VALUE) BY TYPE (PRODUCT CATEGORY) (2012-2017)

4.1 United States Cholera Vaccine Sales and Market Share by Type (Product Category) (2012-2017)
4.2 United States Cholera Vaccine Revenue and Market Share by Type (2012-2017)
4.3 United States Cholera Vaccine Price by Type (2012-2017)
4.4 United States Cholera Vaccine Sales Growth Rate by Type (2012-2017)

5 UNITED STATES CHOLERA VACCINE SALES (VOLUME) BY APPLICATION (2012-2017)

5.1 United States Cholera Vaccine Sales and Market Share by Application (2012-2017)
5.2 United States Cholera Vaccine Sales Growth Rate by Application (2012-2017)
5.3 Market Drivers and Opportunities

6 UNITED STATES CHOLERA VACCINE PLAYERS/SUPPLIERS PROFILES AND SALES DATA

6.1 Valneva
  6.1.1 Company Basic Information, Manufacturing Base and Competitors
  6.1.2 Cholera Vaccine Product Category, Application and Specification
    6.1.2.1 Product A
    6.1.2.2 Product B
  6.1.3 Valneva Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.1.4 Main Business/Business Overview
6.2 PaxVax
  6.2.2 Cholera Vaccine Product Category, Application and Specification
    6.2.2.1 Product A
    6.2.2.2 Product B
  6.2.3 PaxVax Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.2.4 Main Business/Business Overview
6.3 Shantha Biotechnics Limited
  6.3.2 Cholera Vaccine Product Category, Application and Specification
    6.3.2.1 Product A
    6.3.2.2 Product B
  6.3.3 Shantha Biotechnics Limited Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.3.4 Main Business/Business Overview
6.4 Celldex Therapeutics
  6.4.2 Cholera Vaccine Product Category, Application and Specification
    6.4.2.1 Product A
    6.4.2.2 Product B
  6.4.3 Celldex Therapeutics Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.4.4 Main Business/Business Overview
6.5 Merck
  6.5.2 Cholera Vaccine Product Category, Application and Specification
    6.5.2.1 Product A
    6.5.2.2 Product B
  6.5.3 Merck Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.5.4 Main Business/Business Overview
6.6 Ceva Asia
  6.6.2 Cholera Vaccine Product Category, Application and Specification
    6.6.2.1 Product A
    6.6.2.2 Product B
  6.6.3 Ceva Asia Cholera Vaccine Sales, Revenue, Price and Gross Margin (2012-2017)
  6.6.4 Main Business/Business Overview

7 CHOLERA VACCINE MANUFACTURING COST ANALYSIS

7.1 Cholera Vaccine Key Raw Materials Analysis
  7.1.1 Key Raw Materials
  7.1.2 Price Trend of Key Raw Materials
  7.1.3 Key Suppliers of Raw Materials
  7.1.4 Market Concentration Rate of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
  7.2.1 Raw Materials
  7.2.2 Labor Cost
  7.2.3 Manufacturing Expenses
7.3 Manufacturing Process Analysis of Cholera Vaccine

8 INDUSTRIAL CHAIN, SOURCING STRATEGY AND DOWNSTREAM BUYERS

8.1 Cholera Vaccine Industrial Chain Analysis
8.2 Upstream Raw Materials Sourcing
8.3 Raw Materials Sources of Cholera Vaccine Major Manufacturers in 2016
8.4 Downstream Buyers

9 MARKETING STRATEGY ANALYSIS, DISTRIBUTORS/TRADERS

9.1 Marketing Channel
  9.1.1 Direct Marketing
  9.1.2 Indirect Marketing
  9.1.3 Marketing Channel Development Trend
9.2 Market Positioning
  9.2.1 Pricing Strategy
  9.2.2 Brand Strategy
  9.2.3 Target Client
9.3 Distributors/Traders List

10 MARKET EFFECT FACTORS ANALYSIS

10.1 Technology Progress/Risk
  10.1.1 Substitutes Threat
  10.1.2 Technology Progress in Related Industry
10.2 Consumer Needs/Customer Preference Change
10.3 Economic/Political Environmental Change

11 UNITED STATES CHOLERA VACCINE MARKET SIZE (VALUE AND VOLUME) FORECAST (2017-2022)

11.1 United States Cholera Vaccine Sales Volume, Revenue Forecast (2017-2022)
11.2 United States Cholera Vaccine Sales Volume Forecast by Type (2017-2022)
11.3 United States Cholera Vaccine Sales Volume Forecast by Application (2017-2022)
11.4 United States Cholera Vaccine Sales Volume Forecast by Region (2017-2022)

12 RESEARCH FINDINGS AND CONCLUSION

13 APPENDIX

13.1 Methodology/Research Approach
  13.1.1 Research Programs/Design
  13.1.2 Market Size Estimation
  13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
  13.2.1 Secondary Sources
  13.2.2 Primary Sources
13.3 Disclaimer


The report requires updating with new data and is sent in 2-3 business days after order is placed.

List Of Tables

LIST OF TABLES AND FIGURES

Figure Product Picture of Cholera Vaccine
Figure United States Cholera Vaccine Market Size (K Pcs) by Type (2012-2022)
Figure United States Cholera Vaccine Sales Volume Market Share by Type (Product Category) in 2016
Figure Dukoral Product Picture
Figure Shanchol Product Picture
Figure Vaxchora Product Picture
Figure Others Product Picture
Figure United States Cholera Vaccine Market Size (K Pcs) by Application (2012-2022)
Figure United States Sales Market Share of Cholera Vaccine by Application in 2016
Figure Hospital Examples
Table Key Downstream Customer in Hospital
Figure Scientific Research Examples
Table Key Downstream Customer in Scientific Research
Figure Others Examples
Table Key Downstream Customer in Others
Figure United States Cholera Vaccine Market Size (Million USD) by Region (2012-2022)
Figure The West Cholera Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure Southwest Cholera Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Middle Atlantic Cholera Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure New England Cholera Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The South of US Cholera Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure The Midwest Cholera Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cholera Vaccine Sales (K Pcs) and Growth Rate (2012-2022)
Figure United States Cholera Vaccine Revenue (Million USD) and Growth Rate (2012-2022)
Figure United States Cholera Vaccine Market Major Players Product Sales Volume (K Pcs) (2012-2017)
Table United States Cholera Vaccine Sales (K Pcs) of Key Players/Suppliers (2012-2017)
Table United States Cholera Vaccine Sales Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cholera Vaccine Sales Share by Players/Suppliers
Figure 2017 United States Cholera Vaccine Sales Share by Players/Suppliers
Figure United States Cholera Vaccine Market Major Players Product Revenue (Million USD) (2012-2017)
Table United States Cholera Vaccine Revenue (Million USD) by Players/Suppliers (2012-2017)
Table United States Cholera Vaccine Revenue Share by Players/Suppliers (2012-2017)
Figure 2016 United States Cholera Vaccine Revenue Share by Players/Suppliers
Figure 2017 United States Cholera Vaccine Revenue Share by Players/Suppliers
Table United States Market Cholera Vaccine Average Price (USD/Pcs) of Key Players/Suppliers (2012-2017)
Figure United States Market Cholera Vaccine Average Price (USD/Pcs) of Key Players/Suppliers in 2016
Figure United States Cholera Vaccine Market Share of Top 3 Players/Suppliers
Figure United States Cholera Vaccine Market Share of Top 5 Players/Suppliers
Table United States Players/Suppliers Cholera Vaccine Manufacturing Base Distribution and Sales Area
Table United States Players/Suppliers Cholera Vaccine Product Category
Table United States Cholera Vaccine Sales (K Pcs) by Region (2012-2017)
Table United States Cholera Vaccine Sales Share by Region (2012-2017)
Figure United States Cholera Vaccine Sales Share by Region (2012-2017)
Figure United States Cholera Vaccine Sales Market Share by Region in 2016
Table United States Cholera Vaccine Revenue (Million USD) and Market Share by Region (2012-2017)
Table United States Cholera Vaccine Revenue Share by Region (2012-2017)
Figure United States Cholera Vaccine Revenue Market Share by Region (2012-2017)
Figure United States Cholera Vaccine Revenue Market Share by Region in 2016
Table United States Cholera Vaccine Price (USD/Pcs) by Region (2012-2017)
Table United States Cholera Vaccine Sales (K Pcs) by Type (2012-2017)
Table United States Cholera Vaccine Sales Share by Type (2012-2017)
Figure United States Cholera Vaccine Sales Share by Type (2012-2017)
Figure United States Cholera Vaccine Sales Market Share by Type in 2016
Table United States Cholera Vaccine Revenue (Million USD) and Market Share by Type (2012-2017)
Table United States Cholera Vaccine Revenue Share by Type (2012-2017)
Figure Revenue Market Share of Cholera Vaccine by Type (2012-2017)
Figure Revenue Market Share of Cholera Vaccine by Type in 2016
Table United States Cholera Vaccine Price (USD/Pcs) by Types (2012-2017)
Figure United States Cholera Vaccine Sales Growth Rate by Type (2012-2017)
Table United States Cholera Vaccine Sales (K Pcs) by Application (2012-2017)
Table United States Cholera Vaccine Sales Market Share by Application (2012-2017)
Figure United States Cholera Vaccine Sales Market Share by Application (2012-2017)
Figure United States Cholera Vaccine Sales Market Share by Application in 2016
Table United States Cholera Vaccine Sales Growth Rate by Application (2012-2017)
Figure United States Cholera Vaccine Sales Growth Rate by Application (2012-2017)
Table Valneva Basic Information List
Table Valneva Cholera Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Valneva Cholera Vaccine Sales Growth Rate (2012-2017)
Figure Valneva Cholera Vaccine Sales Market Share in United States (2012-2017)
Figure Valneva Cholera Vaccine Revenue Market Share in United States (2012-2017)
Table PaxVax Basic Information List
Table PaxVax Cholera Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure PaxVax Cholera Vaccine Sales Growth Rate (2012-2017)
Figure PaxVax Cholera Vaccine Sales Market Share in United States (2012-2017)
Figure PaxVax Cholera Vaccine Revenue Market Share in United States (2012-2017)
Table Shantha Biotechnics Limited Basic Information List
Table Shantha Biotechnics Limited Cholera Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Shantha Biotechnics Limited Cholera Vaccine Sales Growth Rate (2012-2017)
Figure Shantha Biotechnics Limited Cholera Vaccine Sales Market Share in United States (2012-2017)
Figure Shantha Biotechnics Limited Cholera Vaccine Revenue Market Share in United States (2012-2017)
Table Celldex Therapeutics Basic Information List
Table Celldex Therapeutics Cholera Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Celldex Therapeutics Cholera Vaccine Sales Growth Rate (2012-2017)
Figure Celldex Therapeutics Cholera Vaccine Sales Market Share in United States (2012-2017)
Figure Celldex Therapeutics Cholera Vaccine Revenue Market Share in United States (2012-2017)
Table Merck Basic Information List
Table Merck Cholera Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Merck Cholera Vaccine Sales Growth Rate (2012-2017)
Figure Merck Cholera Vaccine Sales Market Share in United States (2012-2017)
Figure Merck Cholera Vaccine Revenue Market Share in United States (2012-2017)
Table Ceva Asia Basic Information List
Table Ceva Asia Cholera Vaccine Sales (K Pcs), Revenue (Million USD), Price (USD/Pcs) and Gross Margin (2012-2017)
Figure Ceva Asia Cholera Vaccine Sales Growth Rate (2012-2017)
Figure Ceva Asia Cholera Vaccine Sales Market Share in United States (2012-2017)
Figure Ceva Asia Cholera Vaccine Revenue Market Share in United States (2012-2017)
Table Production Base and Market Concentration Rate of Raw Material
Figure Price Trend of Key Raw Materials
Table Key Suppliers of Raw Materials
Figure Manufacturing Cost Structure of Cholera Vaccine
Figure Manufacturing Process Analysis of Cholera Vaccine
Figure Cholera Vaccine Industrial Chain Analysis
Table Raw Materials Sources of Cholera Vaccine Major Players/Suppliers in 2016
Table Major Buyers of Cholera Vaccine
Table Distributors/Traders List
Figure United States Cholera Vaccine Sales Volume (K Pcs) and Growth Rate Forecast (2017-2022)
Figure United States Cholera Vaccine Revenue (Million USD) and Growth Rate Forecast (2017-2022)
Figure United States Cholera Vaccine Price (USD/Pcs) Trend Forecast (2017-2022)
Table United States Cholera Vaccine Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Cholera Vaccine Sales Volume (K Pcs) Forecast by Type (2017-2022)
Figure United States Cholera Vaccine Sales Volume (K Pcs) Forecast by Type in 2022
Table United States Cholera Vaccine Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Cholera Vaccine Sales Volume (K Pcs) Forecast by Application (2017-2022)
Figure United States Cholera Vaccine Sales Volume (K Pcs) Forecast by Application in 2022
Table United States Cholera Vaccine Sales Volume (K Pcs) Forecast by Region (2017-2022)
Table United States Cholera Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cholera Vaccine Sales Volume Share Forecast by Region (2017-2022)
Figure United States Cholera Vaccine Sales Volume Share Forecast by Region in 2022
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources